Literature DB >> 29665166

Silencing synaptic MicroRNA-411 reduces voluntary alcohol consumption in mice.

Dana Most1,2, Nihal A Salem3, Gayatri R Tiwari1, Yuri A Blednov1, R Dayne Mayfield1, R Adron Harris1,2.   

Abstract

Chronic alcohol consumption alters the levels of microRNAs and mRNAs in the brain, but the specific microRNAs and processes that target mRNAs to affect cellular function and behavior are not known. We examined the in vivo manipulation of previously identified alcohol-responsive microRNAs as potential targets to reduce alcohol consumption. Silencing of miR-411 by infusing antagomiR-411 into the prefrontal cortex of female C57BL/6J mice reduced alcohol consumption and preference, without altering total fluid consumption, saccharin consumption, or anxiety-related behaviors. AntagomiR-411 reduced alcohol consumption when given to mice exposed to a chronic alcohol drinking paradigm but did not affect the acquisition of consumption in mice without a history of alcohol exposure, suggesting that antagomiR-411 has a neuroadaptive, alcohol-dependent effect. AntagomiR-411 decreased the levels of miR-411, as well as the association of immunoprecipitated miR-411 with Argonaute2; and, it increased levels of Faah and Ppard mRNAs. Moreover, antagomiR-411 increased the neuronal expression of glutamate receptor AMPA-2 protein, a known alcohol target and a predicted target of miR-411. These results suggest that alcohol and miR-411 function in a homeostatic manner to regulate synaptic mRNA and protein, thus reversing alcohol-related neuroadaptations and reducing chronic alcohol consumption.
© 2018 Society for the Study of Addiction.

Entities:  

Keywords:  Ago2; C57BL/6 J mice; Faah mRNA and Ppard mRNA; GluA2; miR-411; two-bottle choice ethanol drinking

Year:  2018        PMID: 29665166      PMCID: PMC6192878          DOI: 10.1111/adb.12625

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  49 in total

Review 1.  Control of translation and mRNA degradation by miRNAs and siRNAs.

Authors:  Marco Antonio Valencia-Sanchez; Jidong Liu; Gregory J Hannon; Roy Parker
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

2.  Coordinated dysregulation of mRNAs and microRNAs in the rat medial prefrontal cortex following a history of alcohol dependence.

Authors:  J D Tapocik; M Solomon; M Flanigan; M Meinhardt; E Barbier; J R Schank; M Schwandt; W H Sommer; M Heilig
Journal:  Pharmacogenomics J       Date:  2012-05-22       Impact factor: 3.550

Review 3.  Transcriptional and epigenetic mechanisms of addiction.

Authors:  Alfred J Robison; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2011-10-12       Impact factor: 34.870

Review 4.  Molecular mechanisms underlying alcohol-drinking behaviours.

Authors:  Dorit Ron; Segev Barak
Journal:  Nat Rev Neurosci       Date:  2016-07-21       Impact factor: 34.870

5.  The synaptoneurosome transcriptome: a model for profiling the emolecular effects of alcohol.

Authors:  D Most; L Ferguson; Y Blednov; R D Mayfield; R A Harris
Journal:  Pharmacogenomics J       Date:  2014-08-19       Impact factor: 3.550

Review 6.  Gene expression profiling in the human alcoholic brain.

Authors:  Anna S Warden; R Dayne Mayfield
Journal:  Neuropharmacology       Date:  2017-03-15       Impact factor: 5.250

7.  An extensive class of small RNAs in Caenorhabditis elegans.

Authors:  R C Lee; V Ambros
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

8.  Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.

Authors:  Anita C Hansson; Francisco J Bermúdez-Silva; Hanna Malinen; Petri Hyytiä; Irene Sanchez-Vera; Roberto Rimondini; Fernando Rodriguez de Fonseca; George Kunos; Wolfgang H Sommer; Markus Heilig
Journal:  Neuropsychopharmacology       Date:  2006-02-08       Impact factor: 7.853

9.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.

Authors:  Jin Fu; Silvana Gaetani; Fariba Oveisi; Jesse Lo Verme; Antonia Serrano; Fernando Rodríguez De Fonseca; Anja Rosengarth; Hartmut Luecke; Barbara Di Giacomo; Giorgio Tarzia; Daniele Piomelli
Journal:  Nature       Date:  2003-09-04       Impact factor: 49.962

10.  Differential Effects of Chronic and Chronic-Intermittent Ethanol Treatment and Its Withdrawal on the Expression of miRNAs.

Authors:  Gretchen van Steenwyk; Paulina Janeczek; Joanne M Lewohl
Journal:  Brain Sci       Date:  2013-05-03
View more
  7 in total

Review 1.  Protein Translation and Psychiatric Disorders.

Authors:  Sophie Laguesse; Dorit Ron
Journal:  Neuroscientist       Date:  2019-07-04       Impact factor: 7.519

Review 2.  Non-coding RNA in alcohol use disorder by affecting synaptic plasticity.

Authors:  Shuang Zhu; Jiaming Wu; Jian Hu
Journal:  Exp Brain Res       Date:  2022-01-13       Impact factor: 1.972

Review 3.  Current and Future Perspectives of Noncoding RNAs in Brain Function and Neuropsychiatric Disease.

Authors:  Evan J Kyzar; John Peyton Bohnsack; Subhash C Pandey
Journal:  Biol Psychiatry       Date:  2021-08-24       Impact factor: 13.382

4.  Deep sequencing and miRNA profiles in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex.

Authors:  J R Ureña-Peralta; S Alfonso-Loeches; C M Cuesta-Diaz; F García-García; C Guerri
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

Review 5.  The Epigenetics of the Endocannabinoid System.

Authors:  Rosaria Meccariello; Antonietta Santoro; Stefania D'Angelo; Rossella Morrone; Silvia Fasano; Andrea Viggiano; Riccardo Pierantoni
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

6.  Targeting Epigenetic Mechanisms to Treat Alcohol Use Disorders (AUD).

Authors:  F David Rodriguez
Journal:  Curr Pharm Des       Date:  2021-10-05       Impact factor: 3.116

7.  microRNA expression levels in the nucleus accumbens correlate with morphine-taking but not morphine-seeking behaviour in male rats.

Authors:  Aria Gillespie; Hannah L Mayberry; Mathieu E Wimmer; Stephanie E Sillivan
Journal:  Eur J Neurosci       Date:  2022-03-29       Impact factor: 3.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.